New approach to analyzing genetics underlying spina bifida

Weill Cornell Medicine researchers are using machine learning, a form of artificial intelligence, to shed light on genetic mutations associated with spina bifida.

$5.6 million gift expands debt-free scholarship funding for medical students

Building on their longtime commitment to social justice, equity and diversity, Louise and Leonard Riggio have made a $5.6 million gift to Weill Cornell Medicine to establish a scholarship for Black medical students with financial need.

Reducing copper alters breast cancer metabolism

Depleting copper levels may reduce the production of energy that cancer cells need to travel and establish themselves in other parts of the body by a process referred to as metastasis, according to a new study by investigators from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center.

Home health care workers face their own health challenges

Home health care workers often suffer from poorer physical and mental health, when compared with similar low-wage frontline workers, according to new research by Weill Cornell Medicine.

Tumors differ depending on age of cancer patients

Researchers at Weill Cornell Medicine have identified significant differences in the molecular characteristics of tumors from younger and older cancer patients across several cancer types.

AI innovators to speak at Cornell BrAIn symposium Dec. 9-10

Cornell BrAIn, initiated and led by the College of Arts & Sciences, will host a two-day symposium Dec. 9-10, bringing together innovators in Artificial Intelligence (AI) and neuroscience.

Around Cornell

Brain drain: Why do neurons guzzle fuel even at rest?

Pound for pound, the brain consumes vastly more energy than other organs. Now, researchers at Weill Cornell Medicine have found that the process of packaging neurotransmitters may be responsible for this energy drain.

Targeting brain’s immune cells may block Alzheimer’s

A gene mutation linked to Alzheimer’s disease alters a signaling pathway in certain immune cells of individuals with the disease, according to a new study by scientists at Weill Cornell Medicine.

Q&A: COVID-19 and public health investment

For physician and epidemiologist Dr. Jay Varma, the COVID-19 pandemic underscores not only the importance of public health, but also the powerful and pressing role of governments, academic medical centers and other organizations to work together on emerging health threats.